Correlation Between Emergent Biosolutions and Cumberland Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Cumberland Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Cumberland Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and Cumberland Pharmaceuticals, you can compare the effects of market volatilities on Emergent Biosolutions and Cumberland Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Cumberland Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Cumberland Pharmaceuticals.
Diversification Opportunities for Emergent Biosolutions and Cumberland Pharmaceuticals
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Emergent and Cumberland is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Cumberland Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cumberland Pharmaceuticals and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Cumberland Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cumberland Pharmaceuticals has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Cumberland Pharmaceuticals go up and down completely randomly.
Pair Corralation between Emergent Biosolutions and Cumberland Pharmaceuticals
Considering the 90-day investment horizon Emergent Biosolutions is expected to generate 2.28 times more return on investment than Cumberland Pharmaceuticals. However, Emergent Biosolutions is 2.28 times more volatile than Cumberland Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Cumberland Pharmaceuticals is currently generating about -0.02 per unit of risk. If you would invest 1,246 in Emergent Biosolutions on August 29, 2024 and sell it today you would lose (243.00) from holding Emergent Biosolutions or give up 19.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Emergent Biosolutions vs. Cumberland Pharmaceuticals
Performance |
| Timeline |
| Emergent Biosolutions |
| Cumberland Pharmaceuticals |
Emergent Biosolutions and Cumberland Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Emergent Biosolutions and Cumberland Pharmaceuticals
The main advantage of trading using opposite Emergent Biosolutions and Cumberland Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Cumberland Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cumberland Pharmaceuticals will offset losses from the drop in Cumberland Pharmaceuticals' long position.| Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |